With the SARS-CoV-2 Inhibition by Hybrid Graphene Nanoplatelet/Metal Oxide Powders announcement, Share Talk spoke with CEO, Neill Ricketts.
Neill Ricketts, CEO of Versarien Plc (VRS.L) Interview
Avacta Group PLC (AVCT.L) SARS-CoV-2 Rapid Antigen Test Update
Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISIONTM platforms, is pleased to announce significant progress in the development
4d Pharma PLC (DDDD.L) Longevity extends Business Combination deadline
Longevity receives shareholder approval to extend business combination deadline
Genedrive PLC (GDR.L) HCV ID Kit demonstrates high clinical accuracy in India study
Hepatitis C virus testing kit reveals 100% sensitivity and specificity when compared to Abbott Realtime HCV test
TPI provides its latest research note on Scancell Holdings plc (SCLP.L).
The transformative phase of capital raising that Scancell has undertaken to date in 2020 now appears to have drawn to a close.
Open Orphan PLC (ORPH.L) Collaboration with HIC-VAC and Wellcome Trust
Open Orphan, a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials is pleased to
Dr Gareth Cave, Founder and Director of Pharm2Farm Limited Interview
Pharm2Farm Limited (“P2F”) anti-viral surgical mask project
Braveheart Inv Group (BRH.L) Share transactions in Remote Monitored Systems plc
Braveheart announces that on 16 and 17 November 2020, it sold a total of 287,400,000 ordinary shares in Remote Monitored System plc (“RMS”) at a weighted average price of approximately
Omega Diagnostics Gp (ODX.L) UK-RTC Update
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the press release issued today by the UK Rapid Test Consortium (“UK-RTC”), of which
Provexis PLC (PXS.L) Exclusive Distribution Agreement for Chinese CBEC
Provexis, the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow® heart-health functional food ingredient, is pleased to announce it has entered into a distribution agreement with a company
Remote Monitored Sys (RMS.L) Pharm 2 Farm Update and Issue of Equity
Remote Monitored Systems plc, the AIM quoted company, announces that it has retained the services of a consultant for business development and sales and marketing in relation to its wholly-owned
